Nipple-Areola Complex Sensitivity After the Section of Periareolar Dermis in Breast Reduction
NCT ID: NCT01789450
Last Updated: 2013-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2013-06-30
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction
NCT01208974
Comparison of Nipple-areolar Complex Sensation According to Incision Types in Nipple-sparing Mastectomy
NCT05917834
Preoperative Evaluation of 3D Reconstruction Tool for Nipple-sparing Mastectomy
NCT06071234
Investigate Wound Healing, Aesthetics & Pt Satisfaction Post NAC Reconstruction Using a Decellularized Donor NAC Graft
NCT05484934
Nipple Sparing Mastectomy - Cosmetic Outcomes
NCT01002014
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In patients whose CAP should be mobilized through large distances in order to correct breast ptosis, or in cases of dense breasts where noted little slip of skin over the breast parenchyma, the periareolar dermis causes limitation on the mobility of the NAC.
In clinical practice, there is a greater mobilization of NAC when making a careful section of the dermis after decortication. In contrast, the appearance of partial necrosis in these cases has become a rarity, as no case of total necrosis was observed.
Given the technical benefit observed due to greater mobilization, there is no report in the literature about how behaves the sensitivity of the NAC in these cases.
To evaluate the sensitivity of the NAC will be used Semmes-Weisnstein's monofilament. Each point will be obtained five measurements. The largest will be scorned and the lowest value. The final value of each point corresponds to an arithmetic mean of the three remaining values.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Section of Periareolar Dermis
Section of Periareolar Dermis
Section of Periareolar Dermis in Breast Reduction.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Section of Periareolar Dermis in Breast Reduction.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who after consultation with the surgeon who led the research presents realistic expectation, being safe with the possible outcome of the surgery;
* Patients who undertake to comply with the protocol previously presented and discussed with them;
Exclusion Criteria
* Patients with body mass index (BMI) greater than 34.9;
* Patients with severe anemia;
* Patients with neurological disease;
* Patients with impairment cardiovascular;
* Metabolic diseases - diabetes;
* Patients with autoimmune disease;
* Menopausal patients
* Patients with collagen disease;
* Patients with psychiatric disorders.
21 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Federal de Pernambuco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jairo Zacchê de Sá
Jairo Zacchê de Sá
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jairo Z Sá, surgeon
Role: PRINCIPAL_INVESTIGATOR
Hospital das Clínicas da Universidade Federal de Pernambuco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital das clínicas da UFPE
Recife, Pernambuco, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UFPE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.